Nanisx, a device company specializing in the development of less exposure spine surgery technologies for ASCs, has appointed former Medtronic sales executive David Flickinger as its new CEO.
Mr. Flickinger has held sales roles at Medtronic, NuVasive and Surgalign.
"As an ever-greater number of spine procedures transition to the outpatient setting, we are among the first to focus our cutting-edge techniques and technologies for the ASC ecosystem to lead in improving less invasive care for patients," Mr. Flickinger said in a Sept. 27 press release. "I'm looking forward to bringing the leadership and commercial expertise required for these therapies to reach their full potential."